Administrative Core
Administrative Core
批准号:
10262931
负责人:
ROBERT A. LAFYATIS
金额:
$15.82万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2023-08-31
关键词:
Advisory CommitteesAreaBioinformaticsBiological MarkersBostonBudgetsClinicalCollaborationsCommunicationCountryCritiquesEnsureEnvironmentFosteringGeographyGoalsHuman ResourcesIndividualInternationalInterstitial Lung DiseasesInvestigationLeadLeadershipLungLung diseasesMedical centerMentorsMissionNational Institute of Arthritis and Musculoskeletal and Skin DiseasesOutcomePathogenesisPathway interactionsPatientsPhysiciansPlayPrincipal InvestigatorProgram ReviewsRecommendationReportingResearch PersonnelScientistSiteStructureStudy SectionSupervisionSystemic SclerodermaSystems BiologyTechnologyTimeUniversitiesWorkbasedesignexperiencemeetingsnovelnovel therapeuticsoperationprecision medicineprogramspulmonary arterial hypertensionskin disordersuccesstranslational studyweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Administrative Core plays a key role in the overall success of this CORT. The main goal of the
Administrative Core is to foster a scientific environment that promotes the overall CORT objectives: to
advance the understanding of systemic sclerosis (SSc) pathogenesis and to discover novel therapies for
patients with SSc. Dr. Robert Lafyatis will lead the CORT and chair the Executive Committee, composed of
the principal investigators of each of the projects and cores. Dr. Lafyatis has extensive administrative
experience in leading program projects, study sections, and international meetings. He also has clinical and
scientific experience in all of the scientific areas to be studied by CORT investigators. Dr. Rama Mallampalli,
CORT Associate Director, Dr. Harrison Farber, Boston University Site Director and Dr. Michael Whitfield,
Dartmouth Medical Center Site Director will assist Drs. Lafyatis in leading the CORT. Dr. Mallampalli has
extensive experience in translational investigation into pulmonary disease and broad administrative
experience that includes leading one of the largest pulmonary sections in the country. Dr. Farber is known
internationally for his work on pulmonary arterial hypertension associated with SSc, and Dr. Whitfield in
bioinformatics and systems biology. The administrative core will organize monthly Executive Committee
meetings that will serve both as a time to discuss any administrative problems, but more importantly as a time
for scientific exchange between investigators. It will assemble a highly-experienced Advisory Committee
composed of physician-scientists, working in the fields of SSc skin disease, interstitial lung disease, pulmonary
arterial hypertension, biomarkers and clinical outcomes. The Administrative Core committee will organize
annual review by the Advisory Committee to critique progress, probe obstacles, and provide advice for new
scientific directions. The CORT Administrative Core will manage budgets, assist the director in preparing
reports, manage the website, supervise trainess, and arrange enrichment seminars. The Administrative Core
will serve eight basic functions: 1) Provide leadership for individual project and cores, and encourage
cooperation and collaboration between projects and cores; 2) Provide day-to-day scientific oversight of the
program as a whole by maintaining communication with and among project and core investigators; 3) Ensure
communication and coordination between the University of Pittsburgh with Boston University and the
Dartmouth Site Investigators; 4) Provide mechanisms for external oversight and review for the program
project; 5) Provide administrative support for the program including personnel, financial and other
management functions; 6) Assess the scientific merit and programmatic value of Pilot and Feasibility Projects
and make recommendations for submission to the NIAMS; 7) Provide enrichment opportunities for
investigators, and 8) Organize mentoring for young investigators. Through these activities the Administrative
Core will provide key support and coordination for all CORT functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10404140
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2022
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Cell epigenetics & communication in systemic sclerosis and localized scleroderma skin disease
-
批准号:10404143
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2022
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Cell epigenetics & communication in systemic sclerosis and localized scleroderma skin disease
-
批准号:10705648
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2022
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis
-
批准号:10705585
-
项目类别:
-
资助金额:$156.58万
-
财政年份:2022
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis
-
批准号:10404139
-
项目类别:
-
资助金额:$153.48万
-
财政年份:2022
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Administrative Core
-
批准号:10705623
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2022
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Open chromatin and transcriptional regulation of dermal myofibroblasts in SSc
-
批准号:9912525
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2019
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
NIAMS: Center for Research Translation (CORT)
-
批准号:10317277
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
NIAMS: CORT
-
批准号:8924900
-
项目类别:
-
资助金额:$162.3万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
NIAMS: CORT
-
批准号:8089903
-
项目类别:
-
资助金额:$165.26万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
-
批准号:9370321
-
项目类别:
-
资助金额:$130.93万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
NIAMS: CORT
-
批准号:8326628
-
项目类别:
-
资助金额:$162.33万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
NIAMS: CORT
-
批准号:8531154
-
项目类别:
-
资助金额:$154.19万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Project 1: Systemic Sclerosis Skin Biomarkers & Therapeutics
-
批准号:10022107
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
-
批准号:10022096
-
项目类别:
-
资助金额:$130.02万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
-
批准号:10476752
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Rheumatic Diseases Research Core Centers
-
批准号:8326651
-
项目类别:
-
资助金额:$63.01万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
-
批准号:10262930
-
项目类别:
-
资助金额:$135.63万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Project 1 Biomarkers of disease activity and progression in systemic sclerosis
-
批准号:8135919
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
Rheumatic Diseases Research Core Centers
-
批准号:8136385
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2011
-
负责人:ROBERT A. LAFYATIS
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: